Article
Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells.
International journal of immunopathology and pharmacology - 1 Jan 2000
Altorjay I, Veréb Z, Serfozo Z, Bacskai I, Bátori R, Erdodi F, Udvardy M, Sipka S, Lányi Á, Rajnavölgyi É, Palatka K
Abstract excerpt
The aim of this study is to investigate the effect of sera obtained from patients of Crohn's disease treated by anti-TNF-alpha antibody (Infliximab) on the expression of endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor receptor-2 (VEGFR2) protein in human umbilical vein endothelial cells (HUVEC) cultured in vitro. HUVEC was cultured in the presence of sera derived from patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
